Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Moleculin Biotech stock
Own Moleculin Biotech stock in just a few minutes.
Moleculin Biotech, Inc is a biotechnology business based in the US. Moleculin Biotech shares (MBRX) are listed on the NASDAQ and all prices are listed in US Dollars. Moleculin Biotech employs 10 staff and has a market cap (total outstanding shares value) of USD$105 million.
How to buy shares in Moleculin Biotech
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Moleculin Biotech. Find the stock by name or ticker symbol: MBRX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Moleculin Biotech reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Moleculin Biotech, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Moleculin Biotech. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Moleculin Biotech share price
Use our graph to track the performance of MBRX stocks over time.Moleculin Biotech shares at a glance
Information last updated 2021-04-16.
| 52-week range | USD$3.1601 - USD$9.3 |
|---|---|
| 50-day moving average | USD$4.0188 |
| 200-day moving average | USD$4.7423 |
| Wall St. target price | USD$20.33 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-0.32 |
Buy Moleculin Biotech shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Moleculin Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Moleculin Biotech financials
| Gross profit TTM | USD$0 |
|---|---|
| Return on assets TTM | -45.47% |
| Return on equity TTM | -104.14% |
| Profit margin | 0% |
| Book value | $1.539 |
| Market capitalisation | USD$105 million |
TTM: trailing 12 months
Shorting Moleculin Biotech shares
There are currently 514,187 Moleculin Biotech shares held short by investors – that's known as Moleculin Biotech's "short interest". This figure is 71% up from 300,746 last month.
There are a few different ways that this level of interest in shorting Moleculin Biotech shares can be evaluated.
Moleculin Biotech's "short interest ratio" (SIR)
Moleculin Biotech's "short interest ratio" (SIR) is the quantity of Moleculin Biotech shares currently shorted divided by the average quantity of Moleculin Biotech shares traded daily (recently around 2.1 million). Moleculin Biotech's SIR currently stands at 0.24. In other words for every 100,000 Moleculin Biotech shares traded daily on the market, roughly 240 shares are currently held short.
However Moleculin Biotech's short interest can also be evaluated against the total number of Moleculin Biotech shares, or, against the total number of tradable Moleculin Biotech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Moleculin Biotech's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Moleculin Biotech shares in existence, roughly 20 shares are currently held short) or 0.0184% of the tradable shares (for every 100,000 tradable Moleculin Biotech shares, roughly 18 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Moleculin Biotech.
Find out more about how you can short Moleculin Biotech stock.
Moleculin Biotech share dividends
We're not expecting Moleculin Biotech to pay a dividend over the next 12 months.
Have Moleculin Biotech's shares ever split?
Moleculin Biotech's shares were split on a 1:6 basis on 31 January 2021. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Moleculin Biotech shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Moleculin Biotech shares which in turn could have impacted Moleculin Biotech's share price.
Moleculin Biotech share price volatility
Over the last 12 months, Moleculin Biotech's shares have ranged in value from as little as $3.1601 up to $9.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Moleculin Biotech's is 2.0514. This would suggest that Moleculin Biotech's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Moleculin Biotech overview
Moleculin Biotech, Inc. , a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates for the treatment of highly resistant tumors and viruses in the United States. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and hematologic malignancies. It also develops WP1220, an analog of WP1066, which has completed Phase 1 clinical trial for the topical treatment of cutaneous T-cell lymphoma in Poland; WP1234 for the treatment of pancreatic cancer; and WP1732, an analog of WP1066 for the treatment of topical treatment of cutaneous T-cell lymphoma. The company's lead metabolism/glycosylation inhibitor compound is WP1122 to treat cancers and viruses. In addition, it engages in the preclinical development of other drug candidates, including other immune/transcription modulators and antimetabolites, targeting glycolysis and glycosylation.
Frequently asked questions
More guides on Finder
-
T. Rowe Price review
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
-
How to buy ZTO Express Cayman stock
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
-
How to buy Zomedica stock
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
-
How to buy ZoomInfo Technologies stock
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
-
How to buy ZK International Group CoLtd stock
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
-
How to buy Zions Bancorporation National Association stock
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
-
How to buy ZIONL stock
Steps to owning and managing ZIONL, with 24-hour and historical pricing before you buy.
-
How to buy Zentalis Pharmaceuticals stock
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
-
How to buy Yunhong International stock
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
-
How to buy Zealand Pharma A/S stock
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
Ask an Expert